Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: yosi s who wrote (493)	3/28/1998 11:03:00 PM
From: LemonHead	Read Replies (1) \| Respond to of 1491

Lets discuss the drop in volume on Friday? From other anaylis how do you see the stock moving from here? Will it be sideways until we have news or revenue? I'd say the average was above 750,000 for a week and Friday roughly 250,000. Any thoughts? Keith

To: yosi s who wrote (493)	3/29/1998 9:21:00 PM
From: Zvi Steinberg	Read Replies (1) \| Respond to of 1491

Here is a post from AOL's PARS board: Subject: Re: positive future Date: Sun, Mar 29, 1998 14:58 EST From: NATPHARM Message-id: <1998032919583501.OAA09368@ladder01.news.aol.com> SHORT TERM PRICE TARGET 5. AS PHARMACIST, I AM ANXIOUSLY AWAITING DELIVERY TO OUR STORES. BOTH PRODUCTS HAVE BEEN ADDED TO WHOLESALER ON-LINE ORDERING SYSTEM. LOTEMAX IN 5,10 & 15ML. ALREX IN 5 & 10ML. HAVE PLACED ORDERS FOR AUTO SHIP ON ALL 5 SKU's. PRACTICE IN CITY WITH OPTOMETRY SCHOOL AND HAVE HAD 3 CALLS ASKING FOR INFO AND DATE OF AVALIBILITY. OK OPTOMETRISTS HAVE PRESCRIPTIVE AUTHORITY. WILL KEEP INFORMED OF ACTUAL DATE OF DELIVERY, 1ST/2ND/3RD...RX, REFILLS AND PATIENT FEEDBACK. ON A SIDE NOTE: B&L HAS BEEN CALLED ON THE CARPET FOR THE INORDINATE AMOUNT OF ERRORS BY PHARMACISTS B/C ALL OF THEIR PRODUCTS ARE PACKAGED IN LOOK-A-LIKE PACKAGES. THEY ARE KNOWN FOR GOOD PRICING AND BREADTH OF PRODUCT, BUT HOSPITALS AND MAIL-ORDER FIRMS ARE SUGGESTING ALL NEW PACKAGING OR GOING WITH COMPANY THAT ALREADY PROVIDES SUCH. I HAVE NEVER SEEN A B&L REP IN ALL MY 21 YEARS OF PRACTICE. AM CURIOUS TO SEE IF THEY AGGRESSIVELY PROMOTE. I WILL NOTE FIRST REP VISIT OR AD IN PROFESSIONAL JOURNALS. THIS STOCK COULD EASILY SEE DOUBLE DIGITS BY YEARS END.

To: yosi s who wrote (493)	3/30/1998 6:00:00 PM
From: arnie h	Read Replies (3) \| Respond to of 1491

Yosi: Here's one; Cephalon got an approvable letter for Provigil, a drug for narcolepsy. Of course, the other side of the coin is that their Myatrophin is up for review again in April, after being turned down last year. A situation for a real gambler, if you are one. On the Pharmos side, I certainly agree better medicine wins out at the end of the day. The only point I was making is that it sometimes takes more time than one might expect just from the medical aspects. My comments are just aimed at trying to take the sting out so you fellows will hang around when the Elliot gang knocks the stock back. In the meantime, I certainly feel a better about my investment at $3 than I did at $2. I'd be delighted if that turns out to be the floor. Regards, Arnie